← Evidence map

ArticleOncoTargets and therapy2019

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer.

Juan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

47 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31564917